Psychedelic Stocks Archives - Page 54 of 61

ThursdayApr 07, 2022 3:01 pm

UNC Professor Reveals Personal Motive in Studying Psychedelics for Mental Health

Professor Bryan Roth of the University of North Carolina at Chapel Hill says that psychedelic drugs had demonstrated in studies that they had miraculous effects on mental illnesses. Roth also revealed that his research was personal, explaining that his mother suffered from schizophrenia all her life, having had her first episode when he was about five. This, Roth said, has motivated him to learn more about what goes on in the brain. Schizophrenia is a severe mental disorder in which individuals interpret reality in an abnormal way. Patients suffer from delusions, hallucinations and disordered behavior and thinking. After being legally…

TuesdayApr 05, 2022 3:29 pm

Ibogaine Blocks Reward Pathways in Alcohol-Dependent Mice

New research has found that ibogaine blocks some of the abuse-related effects of alcohol in mice. Ibogaine is a natural product extracted from the Tabernanthe iboga plant. It is commonly used during religious ceremonies in the form of tea and is extracted from the plant’s root, bark and stem. Alcohol use disorder is a chronic illness that is characterized by uncontrollable drinking. Symptoms include the repeated consumption of alcohol despite related health and legal problems. This disorder is a leading cause of death and absenteeism globally and is recognized as a global public health issue. However, the current treatments used…

MondayApr 04, 2022 1:46 pm

Activists in Michigan Start Signature Collection Efforts for Psychedelic Legalization Ballot Measure

Earlier this week, activists in the state of Michigan began a signature drive to collect signatures to place an initiative to legalize the sharing, possession and cultivation of psychedelics on the coming statewide ballot. Students for Sensible Drug Policy, a youth-led organization, and the Decriminalize Nature chapter in Michigan are collaborating in this effort. The measure would establish a system for the spiritual and therapeutic use of psychedelic substances. The legislation also permits counseling, spiritual, harm reduction, therapeutic, guidance, supervision and associated supportive services. The initiative also authorizes entities that have acquired a certificate of need from the state’s Department…

FridayApr 01, 2022 3:03 pm

Psychedelics May Boost Connectedness with Nature

A new study has looked into how therapeutic psychedelic administration combined with the calm properties of nature-based settings has the capacity to improve an individual’s mental well-being as well as bolster their relationship with nature. The study was conducted by a team of researchers from the Center for Psychedelic Research at Imperial College in London. Its findings were reported in “Health Psychology.” Contact with nature and the therapeutic administration of psychedelics has been linked to similar psychological mechanisms, including amplified states of transcendent experiences and awe, increased psychological connectedness and reduced rumination, which are all processes associated with improvements in…

ThursdayMar 31, 2022 3:40 pm

Four Psychedelics Movies to Watch

Interest in psychedelic substances has grown significantly these last couple of years as studies unearth more evidence on their benefits and numerous uses. That interest isn’t just confined to uses and benefits; attention has also been paid to psychedelic media. If you’re interested in consuming psychedelic media but aren’t sure where to look, you can start here. Below are a few psychedelic movies that you can watch. “Spirited Away” This animated feature was directed and written by Hayao Miyazaki and animated by Studio Ghibli. It conveys the story of a young girl who enters the world of spirits while she…

WednesdayMar 30, 2022 2:12 pm

New Research Finds That Psilocybin May Help Decrease Weight Gain

Results from a recently conducted animal study show that psilocybin may be effective in decreasing weight gain in obese subjects. Psilocybin is the psychoactive compound found in hallucinogenic mushrooms. Based on prior findings, researchers believe that the compound could be useful in the treatment of various mental health indications, especially when administered in conjunction with therapy. This particular study was carried out by NeonMind Biosciences, an integrated psychedelic drug development and wellness firm. The firm had in the recent past concluded similar research, which found that the psychedelic decreased weight gain in healthy animal subjects. The psychedelic drug company used…

TuesdayMar 29, 2022 2:18 pm

Another City in Michigan Approves Measure to Decriminalize Psychedelics

Last week, the city council of Hazel Park, Michigan, moved to decriminalize psychedelic substances, including ibogaine and psilocybin. Before the city council unanimously passed the measure, the measure’s sponsor, Councilmember Luke Londo, revealed that he’d personally used psilocybin to manage anxiety and depression. The resolution talks about the therapeutic potential of psychedelic substances for conditions such as end-of-life anxiety, depression, cluster headaches and post-traumatic stress disorder. Hazel Park completes the trio of cities in the state of Michigan to enact psychedelic reform, following the cities of Detroit and Ann Arbor. After they decriminalized entheogenic fungi and plants, local legislators in…

MondayMar 28, 2022 2:42 pm

Large Psychedelics Study Maps Conscious Awareness Changes Through Neurotransmitter Systems

Prior studies have found that psychedelic substances can alter states of consciousness. However, until now it was unknown which receptors played a role in this change. New research conducted by a group of scientists from various institutions has demonstrated how a drug-induced change in an individual’s subjective awareness is formed in certain neurotransmitter receptor systems. The team comprised of researchers from the Montreal Neurological Institute-Hospital, SUNY Downstate Health Sciences University, the Broad Institute at Harvard/MIT, the Quebec Artificial Intelligence Institute and McGill University’s Department of Biomedical Engineering. For their study, the scientists collected more than 6,800 testimonials from individuals who…

FridayMar 25, 2022 12:31 pm

Legislators in Connecticut Approve MDMA, Psilocybin Therapy Funding Legislation

Last week, the joint Public Health Committee in Connecticut passed a measure that would allow the state to offer eligible patients access to psychedelic-assisted treatment. The bill, HB 5396, was approved on a noncontroversial basis and will be advancing to the floor for consideration. The legislation requires that the state’s Department of Mental Health and Addiction Services launch a pilot program for psychedelic-assisted therapy to provide eligible patients with funding to receive psilocybin- or MDMA-assisted therapy. The psychedelic-assisted therapy to be offered would be funded and provided specifically for healthcare workers, retired first responders, military veterans and other individuals from…

ThursdayMar 24, 2022 3:42 pm

The Five Most Pivotal Psychedelics Studies So Far

Numerous studies on psychedelics have been conducted since the substances went mainstream a couple of years ago. Since then, a lot has been unearthed about the therapeutic benefits these drugs possess. Here are some important studies on psychedelics that are currently being conducted or are complete. Compass Pathways phase IIb trial Compass Pathways published data on its psychedelic clinical trial, which used psilocybin therapy to manage treatment-resistant depression in 2021. Trial results show that at least 36% of the participants saw a considerable reduction in their symptoms three weeks after the treatment has ended, with almost 30% of these participants…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks